PRTG - Portage Biotech GAAP EPS of -$0.33
2023-08-30 14:23:09 ET
More on Portage Biotech
- Portage surges 12% on team up with Merck to test PORT-2/ Keytruda combo
- Portage Biotech rises after getting full ownership of its anti-cancer agonist platform
- Portage Biotech acquires Tarus Therapeutics, a developer of adenosine receptor antagonists
- Portage initiated overweight at Oppenheimer on potential of iNKT candidates
- Seeking Alpha’s Quant Rating on Portage Biotech
- Earnings data for Portage Biotech
For further details see:
Portage Biotech GAAP EPS of -$0.33